Mar 12, 2026, 01:00 by User Not Found

Clinical Research News | Efforts to improve clinical trials for children with rare diseases must focus on ensuring flexibility while capturing the best data. Florence Mowlem, chief scientific officer at uMotif, joins the most recent episode of The Scope of Things to discuss how thoughtful study design—not just advanced technology—is essential for ensuring reliable data and strong patient participation.

Mar 11, 2026, 09:49 by

Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology.

Mar 11, 2026, 09:49 by

Mar 10, 2026, 08:50 by

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform

Mar 10, 2026, 01:01 by User Not Found

Clinical Research News | As the obesity drug market accelerates, clinical trial design is coming under renewed scrutiny, with growing pressure on sponsors to demonstrate benefits that extend beyond weight loss. The Digital Endpoint Collaboration for Outcomes Development (DECODE) Obesity initiative and cross-industry consortium, led by Ametris, is looking to validate new clinical outcome measures that capture how patients function and feel while on treatment.

Mar 9, 2026, 09:26 by

Services provide expert-led validation, ensuring compliance, efficiency, and data integrity across systems.

Mar 6, 2026, 08:16 by

Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile manufacturing facility. The submission follows the successful execution of multiple aseptic process simulations (APS media-fill batches), completed in accordance with the revised EU GMP Annex 1 (2023) requirements.

Mar 6, 2026, 08:16 by

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.

Mar 6, 2026, 01:00 by User Not Found

Clinical Research News | In the era of decentralized trials and global research networks, the way we manage and deliver clinical data is undergoing a profound transformation. Historically, sponsors relied on manual processes and physical media—USB drives, CDs—to transfer essential trial data to investigator sites at study close-out.

Mar 4, 2026, 09:37 by

Mar 4, 2026, 09:37 by

• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB • Follows close of initial funding round with investment from Stephen Quake and Jay Flatley

Mar 3, 2026, 01:00 by User Not Found

Clinical Research News | Medication nonadherence is a major, longstanding problem in healthcare, with the World Health Organization estimating 50% of patients with chronic diseases are not taking their drugs as prescribed. But MIT engineers are working to solve the problem with an ingestible and bioresorbable RFID-based sensor system, dubbed SAFARI, designed to safely and accurately monitor medication ingestion.

Mar 2, 2026, 11:24 by

Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions.

Mar 2, 2026, 08:23 by

Mar 2, 2026, 08:23 by

Feb 26, 2026, 07:59 by

• Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community • Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively

Feb 26, 2026, 07:59 by

Epigenica has announced the launch of EpiFinder™ cNUC, a unique product for liquid biopsies that significantly expands the capabilities of epigenomic research by delivering deep insights directly from circulating nucleosomes.

Feb 26, 2026, 01:00 by User Not Found

Clinical Research News | Sanofi appoints Belén Garijo as chief executive officer; SEQSTER launches 1-Click Data Refinery; Flatiron Health announces their first Panoramic datasets in the U.K. and Germany for patients with prostate cancer; and more.

Feb 25, 2026, 01:00 by User Not Found

Clinical Research News | Angitia Biopharmaceuticals focuses on postmenopausal osteoporosis, osteogenesis imperfecta, and spinal fusion; Biorce’s clinical trial platform rolls out; and more.

Feb 24, 2026, 06:54 by

Inceptua Group announces the appointment of Kurt J. Hilzinger as Chairman of the Board.